Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

A handful of walnuts a day: could it keep the aging mind sharp?

NCT ID NCT06942351

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 07, 2026 · Last updated Aug 07, 2026

Summary

This study tests whether eating 1.5 ounces of walnuts every day for 12 weeks can improve memory, thinking speed, and flexibility in healthy adults aged 55 and older. Researchers will also check if walnuts reduce inflammation and oxidative stress, and whether they change the balance of bacteria in the gut. Half of the participants will eat walnuts, while the other half will eat calorie-matched crackers as a comparison.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Walnuts
What this could lead to
If walnuts improve cognitive function or gut health in older adults, this could point toward a simple dietary strategy to support healthy aging.
What could go wrong
This is a small, early-stage study, and results may not apply to everyone. Any benefits might be modest, and the study doesn't prove walnuts prevent dementia or other conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jun 2025

Expected to finish

May 2029

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

55 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 55 years or older * Able to hear well enough to understand spoken instructions and questions * Able to see well enough to read and respond to printed instructions and fill out questionnaires (corrective lenses are allowed) * Able to write legibly and move a computer joystick with at least one hand (i.e., no injury or connective tissue or joint disorder that would impair ability to write or make hand movements) * Able to speak, read, and understand English * Score of greater than 79 on water maze learning task * Willing to maintain current eating patterns * Willing and able to complete the cognitive tests * Willing to stop consuming almonds, Brazil nuts, cashews, chestnuts, hazelnuts, macadamia nuts, peanuts, pecans, pistachios, walnuts, persimmons and pomegranates for 14 weeks. - are nuts or contain ellagitannins or ellagic acid - compounds/foods of interest for this study * Willing to limit oak aged wines and spirits to 1 serving/day and limit blackberries (including similar berries like boysenberries, marionberries, and olallieberries), cloudberries, cranberries, currants, elderberries, lingonberries, raspberries, strawberries, wolfberries, other native berries; guava, mango, muscadine grapes, nectarines, peaches, plums, pluots to 1 cup/day for 14 weeks; REMAIN CONSISTENT (consistent intake levels of): Coffee, tea, apple, apricots, blueberries, cherries, grapes (table/common) * Willing to stop probiotic supplements 2 weeks prior to and during the study (14 weeks) Exclusion Criteria: * Consumption of walnuts, pecans, and chestnuts combined greater than 2 oz / week in the past 3 months. * Use of oral antibiotics in the past month * Regular use of oral anti-inflammatory medications in the past month * Nut, wheat, or gluten allergy/intolerance * Pregnant or planning to become pregnant during the study period * Weighs less than 110 pounds * Diagnosis of sickle cell disease * Susceptibility to motion sickness * Consumes 3 or more alcoholic drinks daily * History of smoking tobacco products, including e-cigarettes and vaporizers in the past 2 years (smokeless tobacco use not exclusionary) * Use of psilocybin or cannabis products (including CBD-only products) in the past 2 years * Current treatment for alcohol or other substance use disorder * History of heart attack, heart failure, or stroke, including transient ischemic attack * History of liver disease or kidney disease requiring dialysis * History of cancer in the past 5 years (Skin cancer that was only surgically treated is not exclusionary) * History of bariatric surgery (e.g., gastric bypass, gastric banding, sleeve gastrectomy, etc.) or disorders (e.g., Crohn's disease, unmanaged celiac disease, ulcerative colitis) * History of thyroid disorder that requires medication, but subject is not taking medication * History of chronic bronchitis or emphysema * Diagnosis of dementia or Alzheimer's disease * History of head injury requiring hospitalization or loss of consciousness \> 5 minutes * History of chronic migraines (for at least 3 months, headache occurring on 15 or more days per month, where at least 8 of those headache days have migraine symptoms) * Blood pressure above 159 (systolic) or 99 (diastolic) mm Hg * Corrected vision worse than 20/50 * Score of less than 10/15 on Ishihara color vision test or diagnosis of color blindness * Score of less than 26/30 on Mini-Mental State Exam * Score of greater than 15 on Center for Epidemiologic Depression survey * History of disease or disorder which causes cognitive impairment, including but limited to: attention-deficit/hyperactivity disorder (ADHD), amyotrophic lateral sclerosis, autism, bipolar disorder, Down's syndrome, encephalitis, epilepsy/seizures, human immunodeficiency virus (HIV), Huntington's disease, Korsakoff's psychosis, multiple sclerosis, Parkinson's disease, or psychotic disorders (e.g., schizophrenia, schizoaffective disorder, schizophreniform disorder) * Current and regular use of any of the following medications: insulin, opioids, anti-seizure medications, psychotropic medications: stimulants, anti-psychotics, or medications that cause daytime drowsiness or difficulty concentrating

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Oregon State University

    Corvallis, Oregon, 97331, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.